VRTX Earnings

VRTX reported its earnings on 2026-02-12, showcasing a revenue of 3.19B against an estimate of 3.17B, resulting in a 0.63% surprise. The EPS was 5.03, surpassing the expected 5.14 by -2.14%. The stock experienced a 5.69% price change on the earnings day and a 0.91% change over the next five days, reflecting market reactions to the results.

Following VRTX's earnings announcement on 2026-02-12, the stock price moved by 5.69% on the day of the release. Over the subsequent five days, it saw a 0.91% change. Historically, VRTX's stock price tends to shift by an average of -1.74% in the 10 days leading up to earnings and -2.5% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate VRTX's annual revenue to reach 3.14B, while the EPS is projected at 4.83. These estimates reflect recent revisions, with revenue estimates revised downward by -0.01% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between VRTX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised downward by -0.01%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, VRTX's stock price typically moves by -1.74% in the 10 days before its earnings and -2.5% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 4.83 and revenue of 3.14B.

Vertex's earnings call highlights strong financial performance with a 24% YoY increase in non-GAAP net income and an 85.7% gross margin. The guidance for 2025 shows solid revenue growth and expansion plans for key products like ALYFTREK and JOURNAVX. Despite some uncertainties in guidance specifics, the positive outlook on CASGEVY and renal medicine, alongside substantial cash reserves and share repurchases, suggests a favorable market reaction. The Q&A reinforced confidence in product safety and strategic initiatives, supporting a positive sentiment.